Claus Cursiefen
Corporate Officer/Principal chez Cologne University of Applied Sciences
Profil
Dr. Claus Cursiefen, MD, is Chairman-Ophthalmology Department at Cologne University of Applied Sciences and an Associate Scientist at Harvard Medical School.
He is on the Board of Directors at Novaliq GmbH.
Postes actifs de Claus Cursiefen
| Sociétés | Poste | Début |
|---|---|---|
| Cologne University of Applied Sciences | Corporate Officer/Principal | - |
| Harvard Medical School | Corporate Officer/Principal | - |
Anciens postes connus de Claus Cursiefen
| Sociétés | Poste | Fin |
|---|---|---|
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Novaliq GmbH
Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Health Technology |
